CLRB has been in the news 643% more than usual
May 30, 2024, 12:31 AM
-7.14%
What does CLRB do
Cellectar Biosciences, Inc., based in Florham Park, New Jersey, focuses on developing phospholipid drug conjugates (PDCs) for cancer treatment and imaging, employing 15 full-time staff since its 2005 IPO. The company's pipeline includes iopofosine for targeted cancer therapy, currently under evaluation in Phase 2 and Phase 1 clinical studies for various cancers.
CLRB has been in the news recently: Cellectar Biosciences partners with City of Hope Cancer Center to develop iopofosine for mycosis fungoides, a rare form of non-Hodgkin’s lymphoma, benefiting approximately 30,000 patients.
Firefly Neuroscience, Inc. appoints Brian M. Posner to its Board of Directors as they finalize a merger with WaveDancer, Inc. (WAVD) approved by both companies' stockholders.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.